Risk of new-onset long COVID following reinfection with SARS-CoV-2: community-based cohort study

<p><strong>Background</strong></p> Little is known about the risk of long COVID following reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We estimated the likelihood of new-onset, self-reported long COVID after a second SARS-CoV-2 infection, com...

Full description

Bibliographic Details
Main Authors: Bosworth, ML, Shenhuy, B, Walker, AS, Nafilyan, V, Alwan, NA, O'Hara, ME, Ayoubkhani, D
Format: Journal article
Language:English
Published: Oxford University Press 2023
_version_ 1797111766607462400
author Bosworth, ML
Shenhuy, B
Walker, AS
Nafilyan, V
Alwan, NA
O'Hara, ME
Ayoubkhani, D
author_facet Bosworth, ML
Shenhuy, B
Walker, AS
Nafilyan, V
Alwan, NA
O'Hara, ME
Ayoubkhani, D
author_sort Bosworth, ML
collection OXFORD
description <p><strong>Background</strong></p> Little is known about the risk of long COVID following reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We estimated the likelihood of new-onset, self-reported long COVID after a second SARS-CoV-2 infection, compared to a first infection. <p><strong>Methods</strong></p> We included UK COVID-19 Infection Survey participants who tested positive for SARS-CoV-2 between 1 November 2021 and 8 October 2022. The primary outcome was self-reported long COVID 12–20 weeks after each infection. Separate analyses were performed for those <16 years and ≥16 years. We estimated adjusted odds ratios (aORs) for new-onset long COVID using logistic regression, comparing second to first infections, controlling for sociodemographic characteristics and calendar date of infection, plus vaccination status in participants ≥16 years of age. <p><strong>Results</strong></p> Overall, long COVID was reported by those ≥16 years after 4.0% and 2.4% of first and second infections, respectively; the corresponding estimates among those aged <16 years were 1.0% and 0.6%. The aOR for long COVID after second compared to first infections was 0.72 (95% confidence interval [CI], .63–.81) for those ≥16 years and 0.93 (95% CI, .57–1.53) for those <16 years. <p><strong>Conclusions</strong></p> The risk of new-onset long COVID after a second SARS-CoV-2 infection is lower than that after a first infection for persons aged ≥16 years, though there is no evidence of a difference in risk for those <16 years. However, there remains some risk of new-onset long COVID after a second infection, with around 1 in 40 of those aged ≥16 years and 1 in 165 of those <16 years reporting long COVID after a second infection.
first_indexed 2024-03-07T08:15:00Z
format Journal article
id oxford-uuid:0052bf1f-4aff-47e4-858c-cc9ea0501881
institution University of Oxford
language English
last_indexed 2024-03-07T08:15:00Z
publishDate 2023
publisher Oxford University Press
record_format dspace
spelling oxford-uuid:0052bf1f-4aff-47e4-858c-cc9ea05018812024-01-04T09:52:39ZRisk of new-onset long COVID following reinfection with SARS-CoV-2: community-based cohort studyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:0052bf1f-4aff-47e4-858c-cc9ea0501881EnglishSymplectic ElementsOxford University Press2023Bosworth, MLShenhuy, BWalker, ASNafilyan, VAlwan, NAO'Hara, MEAyoubkhani, D<p><strong>Background</strong></p> Little is known about the risk of long COVID following reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We estimated the likelihood of new-onset, self-reported long COVID after a second SARS-CoV-2 infection, compared to a first infection. <p><strong>Methods</strong></p> We included UK COVID-19 Infection Survey participants who tested positive for SARS-CoV-2 between 1 November 2021 and 8 October 2022. The primary outcome was self-reported long COVID 12–20 weeks after each infection. Separate analyses were performed for those <16 years and ≥16 years. We estimated adjusted odds ratios (aORs) for new-onset long COVID using logistic regression, comparing second to first infections, controlling for sociodemographic characteristics and calendar date of infection, plus vaccination status in participants ≥16 years of age. <p><strong>Results</strong></p> Overall, long COVID was reported by those ≥16 years after 4.0% and 2.4% of first and second infections, respectively; the corresponding estimates among those aged <16 years were 1.0% and 0.6%. The aOR for long COVID after second compared to first infections was 0.72 (95% confidence interval [CI], .63–.81) for those ≥16 years and 0.93 (95% CI, .57–1.53) for those <16 years. <p><strong>Conclusions</strong></p> The risk of new-onset long COVID after a second SARS-CoV-2 infection is lower than that after a first infection for persons aged ≥16 years, though there is no evidence of a difference in risk for those <16 years. However, there remains some risk of new-onset long COVID after a second infection, with around 1 in 40 of those aged ≥16 years and 1 in 165 of those <16 years reporting long COVID after a second infection.
spellingShingle Bosworth, ML
Shenhuy, B
Walker, AS
Nafilyan, V
Alwan, NA
O'Hara, ME
Ayoubkhani, D
Risk of new-onset long COVID following reinfection with SARS-CoV-2: community-based cohort study
title Risk of new-onset long COVID following reinfection with SARS-CoV-2: community-based cohort study
title_full Risk of new-onset long COVID following reinfection with SARS-CoV-2: community-based cohort study
title_fullStr Risk of new-onset long COVID following reinfection with SARS-CoV-2: community-based cohort study
title_full_unstemmed Risk of new-onset long COVID following reinfection with SARS-CoV-2: community-based cohort study
title_short Risk of new-onset long COVID following reinfection with SARS-CoV-2: community-based cohort study
title_sort risk of new onset long covid following reinfection with sars cov 2 community based cohort study
work_keys_str_mv AT bosworthml riskofnewonsetlongcovidfollowingreinfectionwithsarscov2communitybasedcohortstudy
AT shenhuyb riskofnewonsetlongcovidfollowingreinfectionwithsarscov2communitybasedcohortstudy
AT walkeras riskofnewonsetlongcovidfollowingreinfectionwithsarscov2communitybasedcohortstudy
AT nafilyanv riskofnewonsetlongcovidfollowingreinfectionwithsarscov2communitybasedcohortstudy
AT alwanna riskofnewonsetlongcovidfollowingreinfectionwithsarscov2communitybasedcohortstudy
AT oharame riskofnewonsetlongcovidfollowingreinfectionwithsarscov2communitybasedcohortstudy
AT ayoubkhanid riskofnewonsetlongcovidfollowingreinfectionwithsarscov2communitybasedcohortstudy